Intermittent fasting attenuates inflammasome activity in ischemic stroke

Experimental Neurology

Volumn 257, Issue , 2014, Pages 114-119

  Fann, David Yang Wei ^a,e   Santro, Tomislav ^a   Manzanero, Silvia ^a   Widiapradja, Alexander ^a,e   Cheng, Yi Lin ^a,e   Lee, Seung Yoon ^a   Chunduri, Prasad ^a   Jo, Dong Gyu ^b   Stranahan, Alexis M ^d   Mattson, Mark P ^c   Arumugam, Thiruma V ^a,b,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Sungkyunkwan University   (South Korea)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inflammasomes; Intermittent fasting; Ischemic stroke; NLRP1; NLRP3

Indexed keywords

BETA ACTIN; CASPASE 3; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN NLRP1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DENSITOMETRY; DIET RESTRICTION; ENZYME ACTIVATION; FOOD DEPRIVATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION; SIGNAL TRANSDUCTION;

INFLAMMASOMES; INTERMITTENT FASTING; ISCHEMIC STROKE; NLRP1; NLRP3;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY, INTERNAL; CASPASE 1; CYTOKINES; DISEASE MODELS, ANIMAL; FASTING; INFLAMMASOMES; MALE; MICE; MICE, INBRED C57BL; REPERFUSION; SIGNAL TRANSDUCTION; STROKE;

EID: 84900848529     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.017     Document Type: Article

References (46)

1. Aachoui Y., Sagulenko V., Miao E.A., Stacey K.J. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr. Opin. Microbiol. 2013, 16:319-326.
2. Arumugam T.V., Salter J.W., Chidlow J.H., Ballantyne C.M., Kevil C.G., Granger D.N. Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2555-H2560.
3. Arumugam T.V., Granger D.N., Mattson M.P. Stroke and T-cells. Neruomol. Med. 2005, 7:229-242.
4. Arumugam T.V., Phillips T.M., Cheng A., Morrell C.H., Mattson M.P., Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann. Neurol. 2010, 67:41-52.
5. Arumugam T.V., Cheng Y.L., Choi Y., Choi Y.H., Yang S., Yun Y.K., Park J.S., Yang D.K., Thundyil J., Gelderblom M., Karamyan V.T., Tang S.C., Chan S.L., Magnus T., Sobey C.G., Jo D.G. Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke. Mol. Pharmacol. 2011, 80:23-31.
6. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
7. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-e339.
8. Bruey J.M., Bruey-Sedano N., Luciano F., Zhai D., Balpai R., Xu C., Kress C.L., Bailly-Maitre B., Li X., Osterman A., Matsuzawa S., Terskikh A.V., Faustin B., Reed J.C. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129:45-56.
9. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
10. Castello L., Froio T., Maina M., Cavallini G., Biasi F., Leonarduzzi G., Donati A., Bergamini E., Poli G., Chiarpotto E. Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. Free Radic. Biol. Med. 2010, 48:47-54.
11. Dirnagl U. Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann. N. Y. Acad. Sci. 2012, 1268:21-25.
12. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
13. Fann D.Y., Lee S.Y., Manzanero S., Tang S.C., Gelderblom M., Chunduri P., Bernreuther C., Glatzel M., Cheng Y.L., Thundyil J., Widiapradja A., Lok K.Z., Foo S.L., Wang Y.C., Li Y.I., Drummond G.R., Basta M., Magnus T., Jo D.G., Mattson M.P., Sobey C.G., Arumugam T.V. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013, 4:e790.
14. Fann D.Y., Lee S.Y., Manzanero S., Chunduri P., Sobey C.G., Arumugam T.V. Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res. Rev. 2013, 12:941-966.
15. Faustin B., Chen Y., Zhai D., Le Negrate G., Lartigue L., Satterthwait A., Reed J.C. Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3935-3940.
16. Gross O., Thomas C.J., Guarda G., Tschopp J. The inflammasome: an integrated view. Immunol. Rev. 2011, 243:136-151.
17. Guégan C., Vila M., Teismann P., Chen C., Onténiente B., Li M., Friedlander R.M., Przedborski S. Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 2002, 20:553-562.
18. Harvie M.N., Pegington M., Mattson M.P., Frystyk J., Dillon B., Evans G., Cuzick J., Jebb S.A., Martin B., Cutler R.G., Son T.G., Maudsley S., Carlson O.D., Egan J.M., Flyvbjerg A., Howell A. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int. J. Obes. (Lond.) 2011, 35:714-727.
19. He Q., You H., Li X.M., Liu T.H., Wang P., Wang B.E. HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages. Asian Pac. J. Cancer Prev. 2012, 13:1365-1370.
20. Johnson J.B., Summer W., Cutler R.G., Martin B., Hyun D.H., Dixit V.D., Pearson M., Nassar M., Telljohann R., Maudsley S., Carlson O., John S., Laub D.R., Mattson M.P. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 2007, 42:665-674.
21. Jung K.J., Lee E.K., Kim J.Y., Zou Y., Sung B., Heo H.S., Kim M.K., Lee J., Kim N.D., Yu B.P., Chung H.Y. Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm. Res. 2009, 58:143-150.
22. Kang S.J., Wang S., Hara H., Peterson E.P., Namura S., Amin-Hanjani S., Huang Z., Srinivasan A., Tomaselli K.J., Thornberry N.A., Moskowitz M.A., Yuan J. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 2000, 149:613-622.
23. Kang S.J., Wang S., Kuida K., Yuan J. Distinct downstream pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock response. Cell Death Differ. 2002, 9:1115-1125.
24. Kang S.J., Sanchez I., Jing N., Yuan J. Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2003, 23:5455-5460.
25. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., Zhang J., Lee W.P., Roose-Girma M., Dixit V.M. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
26. Lambertsen K.L., Biber K., Finsen B. Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 2012, 32:1677-1698.
27. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
28. Legos J.J., Erhardt J.A., White R.F., Lenhard S.C., Chandra S., Parsons A.A., Tuma R.F., Barone F.C. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res. 2001, 892:70-77.
29. Liu F., Lo C.F., Ning X., Kajkowski E.M., Jin M., Chiriac C., Gonzales C., Naureckiene S., Lock Y.W., Pong K., Zaleska M.M., Jacobsen J.S., Silverman S., Ozenberger B.A. Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell. Signal. 2004, 16:1013-1021.
30. Mager D.E., Wan R., Brown M., Cheng A., Wareski P., Abernethy D.R., Mattson M.P. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J. 2006, 20:631-637.
31. Manzanero S., Gelderblom M., Magnus T., Arumugam T.V. Calorie restriction and stroke. Exp. Transl. Stroke Med. 2011, 3:8.
32. Manzanero S., Erion J.R., Santro T., Steyn F.J., Chen C., Arumugam T.V., Stranahan A.M. Intermittent fasting attenuates increases in neurogenesis after ischemia and reperfusion and improves recovery. J. Cereb. Blood Flow Metab. 2014, 4:897-905.
33. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
34. Mattison J.A., Roth G.S., Beasley T.M., Tilmont E.M., Handy A.M., Herbert R.L., Longo D.L., Allison D.B., Young J.E., Bryant M., Barnard D., Ward W.F., Qi W., Ingram D.K., de Cabo R. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489:318-321.
35. Mattson M.P. Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp. Gerontol. 2000, 35:489-502.
36. Niemann B., Chen Y., Issa H., Silber R.E., Rohrbach S. Caloric restriction delays cardiac ageing in rats: role of mitochondria. Cardiovasc. Res. 2010, 88:267-276.
37. Peart J.N., See Hoe L., Pepe S., Johnson P., Headrick J.P. Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance. Rejuvenation Res. 2012, 15:59-70.
38. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
39. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
40. Tajes M., Gutierrez-Cuesta J., Folch J., Ortuño-Sahagun D., Verdaguer E., Jiménez A., Junyent F., Lau A., Camins A., Pallàs M. Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8). Exp. Gerontol. 2010, 45:702-710.
41. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13798-13803.
42. Tang S.C., Wang Y.C., Li Y.I., Lin H.C., Manzanero S., Hsieh Y.H., Phipps S., Hu C.J., Chiou H.Y., Huang Y.S., Yang W.S., Mattson M.P., Arumugam T.V., Jeng J.S. Functional role of soluble receptor for advanced glycation end products in stroke. Arterioscler. Thromb. Vasc. Biol. 2013, 33:585-594.
43. Weiss E.P., Fontana L. Caloric restriction: powerful protection for the aging heart and vasculature. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1205-H1219.
44. Yu Z.F., Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 1999, 57:830-839.
45. Zhang W.H., Wang X., Narayanan M., Zhang Y., Huo C., Reed J.C., Friedlander R.M. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:16012-16017.
46. Zhao J., Zhang H., Huang Y., Wang H., Wang S., Zhao C., Liang Y., Yang N. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation. Int. Immunopharmacol. 2013, 17:116-122.